Vaginal and anal human papillomavirus infection and seropositivity among female sex workers in Amsterdam, the Netherlands: Prevalence, concordance and risk factors

被引:15
作者
Marra, E. [1 ]
Kroone, N. [1 ]
Freriks, E. [1 ]
van Dam, C. L. [1 ]
Alberts, C. J. [1 ]
Hogewoning, A. A. [1 ,2 ]
Bruisten, S. [1 ,3 ]
van Dijk, A. [1 ]
Kroone, M. M. [1 ]
Waterboer, T. [4 ]
van der Loeff, M. F. Schim [1 ,3 ]
机构
[1] Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, AIII, Amsterdam, Netherlands
[4] German Canc Res Ctr, Infect & Canc Epidemiol, Heidelberg, Germany
关键词
HPV; Prevalence; Concordance; Vaginal; Anal; Seropositivity; Female sex workers; Antibodies; HAWAII HPV COHORT; CERVICAL NEOPLASIA; INTRAEPITHELIAL NEOPLASIA; AS04-ADJUVANTED VACCINE; DOUBLE-BLIND; COSTA-RICA; CONDOM USE; WOMEN; POPULATION; EFFICACY;
D O I
10.1016/j.jinf.2017.12.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: We studied prevalence, risk factors and concordance of vaginal and anal HPV infection and L1 seropositivity among female sex workers (FSW) in Amsterdam. Methods: In 2016, FSW aged >= 18 years having a sexually transmitted infections (STI) consultation were invited to participate. Participation entailed taking vaginal and anal self-swabs. Demographics and sexual behaviour data were collected. HPV DNA was analysed using the SPF10-PCR-DEIA-LiPA25-system-v1. Serum was tested for HPV L1 antibodies using multiplex serology assays. Determinants of vaginal and anal high risk HPV (hrHPV) infection and L1 seropositivity were assessed with logistic regression analyses. Results: We included 304 FSW; median age was 29 years (IQR 25-37). Vaginal and anal hrHPV prevalence were 46% and 55%, respectively. HrHPV L1 seropositivity was 37%. Vaginal-anal hrHPV concordance was strong, but no significant association between vaginal or anal hrHPV infection and seropositivity was found. Having had anal sexual contact was not associated with anal hrHPV infection (P = 0.119). Discussion: Vaginal and anal hrHPV prevalence is high among FSW in Amsterdam, the Netherlands. Promotion of HPV vaccination, preferably at the beginning of the sex (work) career, may be a useful prevention method against hrHPV infection and disease. (C) 2017 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:393 / 405
页数:13
相关论文
共 42 条
[1]  
Alberts CJ, 2017, PAPILLOMAVIRUS RES, V3, P57, DOI 10.1016/j.pvr.2017.01.003
[2]   Anal human papillomavirus infection: prevalence, diagnosis and treatment of related lesions [J].
Benevolo, Maria ;
Dona, Maria Gabriella ;
Ravenda, Paola Simona ;
Chiocca, Susanna .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (05) :465-477
[3]   The causal relation between human papillomavirus and cervical cancer [J].
Bosch, FX ;
Lorincz, A ;
Muñoz, N ;
Meijer, CJLM ;
Shah, KV .
JOURNAL OF CLINICAL PATHOLOGY, 2002, 55 (04) :244-265
[4]   A review of human carcinogens-Part B: biological agents [J].
Bouvard, Veronique ;
Baan, Robert ;
Straif, Kurt ;
Grosse, Yann ;
Secretan, Beatrice ;
El Ghissassi, Fatiha ;
Benbrahim-Tallaa, Lamia ;
Guha, Neela ;
Freeman, Crystal ;
Galichet, Laurent ;
Cogliano, Vincent .
LANCET ONCOLOGY, 2009, 10 (04) :321-322
[5]   Human papillomavirus prevalence, cervical abnormalities and risk factors among female sex workers in Lima, Peru [J].
Brown, B. ;
Blas, M. M. ;
Cabral, A. ;
Byraiah, G. ;
Guerra-Giraldez, C. ;
Sarabia-Vega, V. ;
Carcamo, C. ;
Gravitt, P. E. ;
Halsey, N. A. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2012, 23 (04) :242-247
[6]   Consistent Condom Use Reduces the Genital Human Papillomavirus Burden Among High-Risk Men: The HPV Infection in Men Study [J].
Campbell, Christine M. Pierce ;
Lin, Hui-Yi ;
Fulp, William ;
Papenfuss, Mary R. ;
Salmeron, Jorge J. ;
Quiterio, Manuel M. ;
Lazcano-Ponce, Eduardo ;
Villa, Luisa L. ;
Giuliano, Anna R. .
JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (03) :373-384
[7]   Concordance of prevalence of human papillomavirus DNA in anogenital and oral infections in a high-risk population [J].
Cañadas, MP ;
Bosch, FX ;
Junquera, ML ;
Ejarque, M ;
Font, R ;
Ordoñez, E ;
de Sanjosé, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (03) :1330-1332
[8]   End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age [J].
Castellsague, X. ;
Munoz, N. ;
Pitisuttithum, P. ;
Ferris, D. ;
Monsonego, J. ;
Ault, K. ;
Luna, J. ;
Myers, E. ;
Mallary, S. ;
Bautista, O. M. ;
Bryan, J. ;
Vuocolo, S. ;
Haupt, R. M. ;
Saah, A. .
BRITISH JOURNAL OF CANCER, 2011, 105 (01) :28-37
[9]   Prevalence of and Risk Factors for Anal Human Papillomavirus Infection Among Young Healthy Women in Costa Rica [J].
Castro, Felipe A. ;
Quint, Wim ;
Gonzalez, Paula ;
Katki, Hormuzd A. ;
Herrero, Rolando ;
van Doorn, Leen-Jan ;
Schiffman, Mark ;
Struijk, Linda ;
Rodriguez, Ana Cecilia ;
DelVecchio, Corey ;
Lowy, Douglas R. ;
Porras, Carolina ;
Jimenez, Silvia ;
Schiller, John ;
Solomon, Diane ;
Wacholder, Sholom ;
Hildesheim, Allan ;
Kreimer, Aimee R. .
JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (07) :1103-1110
[10]   The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States [J].
Chesson, Harrell W. ;
Dunne, Eileen F. ;
Hariri, Susan ;
Markowitz, Lauri E. .
SEXUALLY TRANSMITTED DISEASES, 2014, 41 (11) :660-664